On August 29, 2019 Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, reported that management plans to participate at the following events in September 2019 (Press release, Celyad, AUG 29, 2019, View Source [SID1234539118]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Healthcare Conference
Date: Wednesday, September 4, 2019
Presentation Time: 4:10 p.m. EDT
Location: Boston, Massachusetts, USA
Webcast: Celyad’s website, under Events & Webcasts section

CAR-TCR Summit
Date: September 10 – 13, 2019
Location: Boston, Massachusetts, USA

International Conference on Lymphocyte Engineering (ICLE)
Date: September 13 – 15, 2019
Location: London, United Kingdom

KBC Annual Healthcare Conference
Date: Thursday, September 26, 2019
Location: Brussels, Belgium